SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Additional Paid In Capital
SCI Pharmtech Inc
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Additional Paid In Capital
NT$2.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Additional Paid In Capital
NT$2.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Additional Paid In Capital
NT$3.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Additional Paid In Capital
NT$1.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Additional Paid In Capital
NT$7.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Additional Paid In Capital
NT$300.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-3%
|
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Additional Paid In Capital?
Additional Paid In Capital
2.2B
TWD
Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Additional Paid In Capital amounts to 2.2B TWD.
What is SCI Pharmtech Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
10%
Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for SCI Pharmtech Inc have been 18% over the past three years , 11% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet